Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8447 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8232 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8176 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8166 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8146 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8146 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8133 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8125 |
Intermediate Similarity |
NPD1653 |
Approved |
0.811 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8107 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8067 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8037 |
Intermediate Similarity |
NPD37 |
Approved |
0.8024 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7988 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7943 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7941 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7933 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7929 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7927 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7917 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7895 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.787 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7857 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7844 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7834 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7831 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7809 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7803 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7792 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7784 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7778 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7771 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7771 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7771 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7746 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7742 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7742 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7725 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7714 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7701 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7665 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7665 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7627 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7627 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7625 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7622 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7614 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7602 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.759 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7578 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7571 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7571 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7558 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7546 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7533 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7514 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7469 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7469 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7458 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7443 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7439 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7436 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7427 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7421 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7417 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7416 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7412 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7407 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7407 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7407 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7391 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7372 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7349 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7337 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7326 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7325 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7325 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7321 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7293 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7293 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7293 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7289 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7289 |
Intermediate Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.7287 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7283 |
Intermediate Similarity |
NPD919 |
Approved |
0.7267 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7261 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7256 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7246 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7243 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7233 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7222 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7208 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7195 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7186 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7186 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7186 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7186 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7176 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7174 |
Intermediate Similarity |
NPD7906 |
Approved |
0.717 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7161 |
Intermediate Similarity |
NPD8651 |
Approved |
0.716 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7152 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7134 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7126 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD4140 |
Approved |
0.712 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7119 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7118 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7097 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.709 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7083 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7073 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7073 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7073 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7048 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7048 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7047 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7041 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7032 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.703 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7024 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7024 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7024 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7018 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7018 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7018 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7013 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7012 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7012 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7012 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7012 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7011 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.6993 |
Remote Similarity |
NPD5691 |
Approved |
0.6975 |
Remote Similarity |
NPD4340 |
Discontinued |
0.6975 |
Remote Similarity |
NPD447 |
Suspended |
0.6975 |
Remote Similarity |
NPD5735 |
Approved |
0.697 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD3705 |
Approved |
0.6966 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6964 |
Remote Similarity |
NPD5058 |
Phase 3 |
0.6964 |
Remote Similarity |
NPD6666 |
Approved |
0.6964 |
Remote Similarity |
NPD6667 |
Approved |
0.6962 |
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.6961 |
Remote Similarity |
NPD8156 |
Discontinued |
0.6957 |
Remote Similarity |
NPD4578 |
Approved |
0.6957 |
Remote Similarity |
NPD7310 |
Approved |
0.6957 |
Remote Similarity |
NPD7311 |
Approved |
0.6957 |
Remote Similarity |
NPD7312 |
Approved |
0.6957 |
Remote Similarity |
NPD7313 |
Approved |
0.6957 |
Remote Similarity |
NPD4577 |
Approved |
0.6951 |
Remote Similarity |
NPD5588 |
Approved |
0.6951 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6951 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6951 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6946 |
Remote Similarity |
NPD6331 |
Phase 2 |
0.6946 |
Remote Similarity |
NPD7982 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD3225 |
Approved |
0.6935 |
Remote Similarity |
NPD4663 |
Approved |
0.6935
|
Remote Similarity |
NPD8150 |
Discontinued |